We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA ISSUES THREE NEW RISK MANAGEMENT DRAFT GUIDANCES
The item has been added to your shopping cart.
FDA ISSUES THREE NEW RISK MANAGEMENT DRAFT GUIDANCES
May 7, 2004
The FDA last week issued three draft guidances to help drug manufacturers achieve more benefits from drug and biologic development processes while minimizing their risks, as a follow-up to the concept papers it released last spring.